Yahoo · Nov 8, 2026
NRC Health: 3 Key Takeaways for Long-Term Investors
Margin discipline amid heavy implementation spending suggests the company can sustain profitability as contracts mature.
NYSE · NRC
Healthcare · Medical - Healthcare Information Services
$26.16
Down-$1.17 (-4.47%)
Updated Nov 19, 2026, 11:15 PM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NRC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 18, 2026
NRC closed at $26.16 after 21 trading sessions, up 28.80% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | $25.71 | $26.255 | $25.55 | $26.16 | 94.37K |
| Nov 17, 2026 | $26.09 | $26.17 | $25.525 | $25.885 | 79.76K |
| Nov 16, 2026 | $26.45 | $26.67 | $25.985 | $26.33 | 103.7K |
| Nov 13, 2026 | $26.88 | $26.88 | $25.47 | $26.56 | 116.59K |
| Nov 12, 2026 | $26.86 | $27.60 | $26.365 | $26.64 | 93.36K |
| Nov 11, 2026 | $26.76 | $27.15 | $26.49 | $26.86 | 125.98K |
| Nov 10, 2026 | $26.42 | $27.23 | $26.41 | $26.85 | 129.21K |
| Nov 9, 2026 | $26.18 | $27.00 | $25.98 | $26.67 | 69.13K |
| Nov 6, 2026 | $25.45 | $25.97 | $24.98 | $25.86 | 83.42K |
| Nov 5, 2026 | $27.23 | $27.41 | $25.14 | $25.48 | 255.63K |
| Nov 4, 2026 | $24.44 | $27.30 | $24.00 | $27.07 | 247.48K |
| Nov 3, 2026 | $24.26 | $24.26 | $23.51 | $24.07 | 108.97K |
| Nov 2, 2026 | $24.02 | $24.69 | $23.84 | $24.26 | 101.22K |
| Oct 30, 2026 | $23.64 | $24.01 | $23.47 | $23.83 | 86.22K |
| Oct 29, 2026 | $23.72 | $24.40 | $23.33 | $23.49 | 124.94K |
| Oct 28, 2026 | $23.24 | $23.83 | $22.10 | $23.47 | 243.12K |
| Oct 27, 2026 | $22.45 | $23.05 | $21.51 | $21.75 | 105.73K |
| Oct 26, 2026 | $21.85 | $22.60 | $21.525 | $22.45 | 93.9K |
| Oct 23, 2026 | $21.13 | $21.99 | $21.04 | $21.93 | 91.3K |
| Oct 22, 2026 | $20.32 | $21.43 | $20.32 | $21.38 | 70.07K |
| Oct 21, 2026 | $20.69 | $20.73 | $20.18 | $20.31 | 48.31K |
The latest Smart Investors Daily articles mentioning NRC.
Company
Market Activity
Research & News
NRC research
Company profile and research snapshot.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 28, 2026 | Citizens | Market Outperform | — |
| Jul 29, 2026 | Citizens | Market Outperform | — |
| Jun 22, 2026 | Citizens | Market Outperform | — |
No generated briefing is available yet.
Yahoo · Nov 8, 2026
Margin discipline amid heavy implementation spending suggests the company can sustain profitability as contracts mature.
Yahoo · Oct 28, 2026
(NRC) on Tuesday reported earnings of $4.The Lincoln, Nebraska-based company said it had profit of 21 cents per share.
Benzinga · Oct 28, 2026
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $26 to $27.
Yahoo · Oct 28, 2026
Moby summary of National Research Corporation's Q3 2026 earnings call
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning NRC.